Podcast #1 - Executive Dashboards and the Orchestration Layer

• I have pulled together launch dashboards. Most tell you what happened, and by the time the room agrees on why, the window has moved.

• Lou Pillai calls the fix the orchestration layer, and is blunt that it is not a program management exercise.

• The capability worth sitting with: AI can surface the heuristics your 30-year super specialist carries in their head, while the decision is still live.

• One line stays above the dashboard. AI cannot take accountability.

Having launched multiple drugs, I can tell you the ambition was never complicated: get patient support, sales, and reimbursement all operating off their version of the right data. A well run traditional model does achieve that. What it does not do is tell you fast enough when the plan is wrong.

There is a structural reason for the lag, and it rarely gets named. The agency of record owns much of the content and campaign execution. Your team owns field and analytics. Patient support sits behind a firewall commercial teams legally cannot see across. Every function reads the launch through its own lens: access talks access, the business talks commercial velocity, and nobody is holding the whole picture.

On the episode, Lou Pillai was direct about what the orchestration layer is not. It is not a program management exercise. It is a fundamental rethink of how everybody comes together before and during a launch. People, software, and agents acting on each other's behalf, tying the pieces into one system.

Two things make that newly possible. Systemic orchestration lets every function work from the same signals without breaching the wall between commercial, medical, and patient support, so everyone sees an integrated view and the loop still closes. And AI can now hold intent and context in a way the deterministic closed-loop tools of a decade ago never could, flagging where a launch is off track, and why, without a meeting being convened for every signal.

The capability Lou pointed to is the one worth sitting with. Most organizations have a super specialist who carries thirty years of launches in their head and can tell you exactly what went wrong in that region, on that brand, in that market, and how they fixed it. That knowledge has always walked out at 6pm. AI can tease those heuristics apart and put them in front of a decision maker while the decision is still live.

Which is what an executive dashboard should have been all along: the data at the fingertips of the people who can act, inside the first month or two. A pharma launch has an opening weekend, much like a film. People decide early whether this drug reaches peak sales.

One line from Lou is worth keeping above the dashboard: AI cannot take accountability. It surfaces the pattern. The room still owns the call.

Listen to this part of the conversation here: https://vimeo.com/1210362697?share=copy&fl=sv&fe=ci#t=1068.

#IvyTreeAdvisors #PharmaLaunch #AIinPharma #DigitalHealth #MedicalAffairs #LaunchExcellence #Pharma